{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:56:24Z","timestamp":1776207384120,"version":"3.50.1"},"reference-count":47,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Sofia (Council of Medical Science)","award":["D-298\/18"],"award-info":[{"award-number":["D-298\/18"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>Delafloxacin is one of the newest fluoroquinolones with a unique structure, determining better pharmacokinetic and pharmacodynamic properties, a better safety profile, and a broader spectrum of activity compared to older quinolones. We aimed to examine the susceptibility rates of delafloxacin, the genetic mechanisms contributing to resistance, and the serotype distribution in both invasive and non-invasive Streptococcus agalactiae strains. A total of 301 streptococcal strains were tested for minimal inhibitory concentration (MIC) to delafloxacin. All delafloxacin-resistant strains were subjected to serotyping, PCRs for quinolone-resistant genes, and sequence analysis for missense and silent mutations. Among the tested isolates, we found a 5.6% non-susceptibility rate to delafloxacin. The MICs ranged between 0.09 and 0.38 \u00b5g\/mL, with a breakpoint for nonsusceptibility set as &gt;0.03 \u00b5g\/L, according to EUCAST criteria. All resistant isolates harboured missense mutations that led to amino acid substitutions in both GyrA (S81L) and ParC (S79F). Two common serotypes were determined among the resistant isolates: V (47.1%) and III (41.2%). Two strains were non-typable (11.7%). A statistical significance in the distribution of serotypes between delafloxacin-resistant and delafloxacin-susceptible strains was found. These findings highlight a concerning pattern of drug resistance developing prior to the introduction of a new medication, attributed to the extensive use of current antibiotics.<\/jats:p>","DOI":"10.3390\/cimb47060446","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T05:23:16Z","timestamp":1749619396000},"page":"446","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Genetic Mechanisms of Antimicrobial Non-Susceptibility to Novel Fluoroquinolone Delafloxacin Among Bulgarian Clinical Isolates of Streptococcus agalactiae"],"prefix":"10.3390","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0429-9252","authenticated-orcid":false,"given":"Vasil","family":"Boyanov","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Medical Faculty, Medical University of Sofia, Zdrave Str. 2, 1431 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Alexandrova","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Medical Faculty, Medical University of Sofia, Zdrave Str. 2, 1431 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raina","family":"Gergova","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Medical Faculty, Medical University of Sofia, Zdrave Str. 2, 1431 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1099\/jmm.0.000475","article-title":"Mechanisms of quinolone action and resistance: Where do we stand?","volume":"66","author":"Correia","year":"2017","journal-title":"J. Med. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1039\/C9MD00120D","article-title":"Quinolone antibiotics","volume":"10","author":"Pham","year":"2019","journal-title":"Medchemcomm"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e0042824","DOI":"10.1128\/aac.00428-24","article-title":"Pharmacokinetics and pharmacodynamics of intravenous delafloxacin in healthy subjects: Model-based dose optimization","volume":"68","author":"Lv","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/cid\/ciy1079","article-title":"Profile of a Novel Anionic Fluoroquinolone-Delafloxacin","volume":"68","author":"Tulkens","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Kocsis, B., Guly\u00e1s, D., and Szab\u00f3, D. (2021). Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline. Antibiotics, 10.","DOI":"10.3390\/antibiotics10121506"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40121-018-0198-x","article-title":"Delafloxacin: Place in Therapy and Review of Microbiologic, Clinical and Pharmacologic Properties","volume":"7","author":"Jorgensen","year":"2018","journal-title":"Infect. Dis. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/jac\/dkx543","article-title":"Clinical review of delafloxacin: A novel anionic fluoroquinolone","volume":"73","author":"Mogle","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1093\/jac\/dks307","article-title":"Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: Resistance selection and characterization","volume":"67","author":"Remy","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Boyanova, L., Markovska, R., Medeiros, J., Gergova, G., and Mitov, I. (2020). Delafloxacin against Helicobacter pylori, a potential option for improving eradication success?. Diagn. Microbiol. Infect. Dis., 96.","DOI":"10.1016\/j.diagmicrobio.2019.114980"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s40265-020-01358-0","article-title":"Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections","volume":"80","author":"Scott","year":"2020","journal-title":"Drugs"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Rusu, A., Lungu, I.A., Moldovan, O.L., Tanase, C., and Hancu, G. (2021). Structural Characterization of the Millennial Antibacterial (Fluoro)Quinolones-Shaping the Fifth Generation. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13081289"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Zasheva, A., Batcheva, E., Ivanova, K.D., and Yanakieva, A. (2024). Differences in Patient Access to Newly Approved Antibacterial Drugs in EU\/EEA Countries. Antibiotics, 13.","DOI":"10.3390\/antibiotics13111077"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1128\/AAC.46.10.3311-3315.2002","article-title":"Fluoroquinolone-resistant Streptococcus pneumoniae strains occur frequently in elderly patients in Japan","volume":"46","author":"Yokota","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1128\/AAC.47.11.3605-3609.2003","article-title":"First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC","volume":"47","author":"Kawamura","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1128\/AAC.49.6.2495-2497.2005","article-title":"Fluoroquinolone-resistant Streptococcus agalactiae: Epidemiology and mechanism of resistance","volume":"49","author":"Wehbeh","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1179\/joc.2009.21.4.463","article-title":"Characterization of clinical blood isolates of Streptococcus agalactiae with reduced susceptibility to levofloxacin","volume":"21","author":"Llaneza","year":"2009","journal-title":"J. Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bjid.2012.05.003","article-title":"Molecular characterization of the first fluoroquinolone resistant strains of Streptococcus agalactiae isolated in Brazil","volume":"16","author":"Barros","year":"2012","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1128\/AAC.05127-14","article-title":"Emergence of the first levofloxacin-resistant strains of Streptococcus agalactiae isolated in Italy","volume":"59","author":"Piccinelli","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Neemuchwala, A., Teatero, S., Patel, S.N., and Fittipaldi, N. (2016). Fluoroquinolone Resistance among Clonal Complex 1 Group B Streptococcus Strains. Can. J. Infect. Dis. Med. Microbiol., 2016.","DOI":"10.1155\/2016\/6403928"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Li, C., Sapugahawatte, D.N., Yang, Y., Wong, K.T., Lo, N.W.S., and Ip, M. (2020). Multidrug-Resistant Streptococcus agalactiae Strains Found in Human and Fish with High Penicillin and Cefotaxime Non-Susceptibilities. Microorganisms, 8.","DOI":"10.3390\/microorganisms8071055"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1751-7915.2008.00063.x","article-title":"Mechanism of action of and resistance to quinolones","volume":"2","author":"Madurga","year":"2009","journal-title":"Microb. Biotechnol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e02609-16","DOI":"10.1128\/AAC.02609-16","article-title":"In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014","volume":"61","author":"Pfaller","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1093\/cid\/ciz787","article-title":"Emergence of Delafloxacin-Resistant Staphylococcus aureus in Brooklyn, New York","volume":"70","author":"Iregui","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Bola\u00f1os, S., Acebes, C., Mart\u00ednez-Exp\u00f3sito, \u00d3., Boga, J.A., Fern\u00e1ndez, J., and Rodr\u00edguez-Lucas, C. (2024). Role of parC Mutations at Position 84 on High-Level Delafloxacin Resistance in Methicillin-Resistant Staphylococcus aureus. Antibiot., 13.","DOI":"10.3390\/antibiotics13070641"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Turban, A., Gu\u00e9rin, F., Dinh, A., and Cattoir, V. (2023). Updated Review on Clinically-Relevant Properties of Delafloxacin. Antibiotics, 12.","DOI":"10.3390\/antibiotics12081241"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1016\/j.vaccine.2020.08.052","article-title":"Systematic review of Group B Streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates","volume":"38","author":"Paul","year":"2020","journal-title":"Vaccine"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Sadeh, M., Salehi-Abargouei, A., Azartoos, N., Mirzaei, F., and Khalili, M. (2020). Distribution of Streptococcus agalactiae Among Iranian Women from 1992 to 2018: A Systematic Review and Meta-Analysis. Jundishapur J. Microbiol., 13.","DOI":"10.5812\/jjm.102314"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Gergova, R., Boyanov, V., Muhtarova, A., and Alexandrova, A. (2024). A Review of the impact of streptococcal infections and antimicrobial resistance on human health. Antibiotics, 13.","DOI":"10.3390\/antibiotics13040360"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s15010-022-01965-x","article-title":"Neonatal invasive disease caused by Streptococcus agalactiae in Europe: The DEVANI multi-center study","volume":"51","author":"Lohrmann","year":"2023","journal-title":"Infection"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/microbiolspec.GPP3-0007-2018","article-title":"Group B streptococcus (Streptococcus agalactiae)","volume":"7","author":"Raabe","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.pathol.2020.06.006","article-title":"Whole genome sequencing for antimicrobial resistance mechanisms, virulence factors and clonality in invasive Streptococcus agalactiae blood culture isolates recovered in Australia","volume":"52","author":"Stewart","year":"2020","journal-title":"Pathology"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Liu, Z., Jiang, X., Li, J., Ji, W., Zhou, H., Gong, X., Miao, B., Meng, S., Duan, L., and Shi, Q. (2023). Molecular characteristics and antibiotic resistance mechanisms of clindamycin-resistant Streptococcus agalactiae isolates in China. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1138039"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jamainternmed.2018.7269","article-title":"Epidemiology of invasive group B streptococcal infections among nonpregnant adults in the United States, 2008\u20132016","volume":"179","author":"Watkins","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"ref_35","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (2025, January 01). Breakpoint tables for interpretation of MICs and zone diameters. Version 15.0., Available online: http:\/\/www.eucast.org."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Delannoy, C.M., Crumlish, M., Fontaine, M.C., Pollock, J., Foster, G., Dagleish, M.P., Turnbull, J.F., and Zadoks, R.N. (2013). Human Streptococcus agalactiae strains in aquatic mammals and fish. BMC Microbiol., 13.","DOI":"10.1186\/1471-2180-13-41"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1128\/JCM.00159-07","article-title":"Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci","volume":"45","author":"Poyart","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1128\/AAC.01716-08","article-title":"Invasive Streptococcal Disease Working Group. Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections","volume":"53","author":"Murayama","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/nyas.12830","article-title":"Mechanisms of drug resistance: Quinolone resistance","volume":"1354","author":"Hooper","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"505","DOI":"10.33073\/pjm-2024-042","article-title":"Antibiotic Resistance and Serotypes Distribution in Streptococcus agalactiae Bulgarian Clinical Isolates During the Years of 2021-2024","volume":"73","author":"Boyanov","year":"2024","journal-title":"Pol. J. Microbiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5152\/balkanmedj.2021.20152","article-title":"Emergence of multidrug-resistant and -hypervirulent Streptococcus agalactiae in Bulgarian patients","volume":"38","author":"Gergova","year":"2021","journal-title":"Balk. Med. J."},{"key":"ref_42","first-page":"373","article-title":"Resistance Rates of Streptococcus agalactiae Strains Isolated from Urine Samples to Various Antibiotics","volume":"13","author":"Aygar","year":"2023","journal-title":"Value Health Sci."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Wang, J., Zhang, Y., Lin, M., Bao, J., Wang, G., Dong, R., Zou, P., Chen, Y., Li, N., and Zhang, T. (2023). Maternal colonization with group B Streptococcus and antibiotic resistance in China: Systematic review and meta-analyses. Ann. Clin. Microbiol. Antimicrob., 22, Erratum in Ann. Clin. Microbiol. Antimicrob. 2023, 22, 17.","DOI":"10.1186\/s12941-023-00553-7"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/phar.2050","article-title":"What Is Old Is New Again: Delafloxacin, a Modern Fluoroquinolone","volume":"38","author":"Cho","year":"2018","journal-title":"Pharmacotherapy"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/cid\/ciz006","article-title":"Analysis of Pooled Phase III Efficacy Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections","volume":"68","author":"Giordano","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.eimc.2020.09.016","article-title":"In vitro activity of delafloxacin against highly levofloxacin-resistant invasive isolates of Streptococcus pneumoniae","volume":"40","author":"Cercenado","year":"2022","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.37201\/req\/107.2023","article-title":"Efficacy of delafloxacin alone and in combination with cefotaxime against cefotaxime non-susceptible invasive isolates of Streptococcus pneumoniae","volume":"37","author":"Sanz","year":"2024","journal-title":"Rev. Esp. Quimioter."}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/47\/6\/446\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:49:52Z","timestamp":1760032192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/47\/6\/446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["cimb47060446"],"URL":"https:\/\/doi.org\/10.3390\/cimb47060446","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]}}}